These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18348471)

  • 1. Influence of cefoperazone and azithromycin on the pharmacokinetics of pazufloxacin in rats.
    Lou S; Li W; Hu Q
    Eur J Drug Metab Pharmacokinet; 2007; 32(4):219-23. PubMed ID: 18348471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose pharmacokinetics and dose proportionality of intravenous pazufloxacin mesilate in healthy Korean volunteers.
    Lee J; Seong SJ; Lim MS; Park SM; Park J; Seo JJ; Lee HW; Yoon YR
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):921-8. PubMed ID: 22809012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinant of the distribution volume at steady state for novel quinolone pazufloxacin in rats.
    Hayakawa H; Takagi K; Takano YF; Kawamura Y; Tsuji A
    J Pharm Pharmacol; 2002 Sep; 54(9):1229-36. PubMed ID: 12356277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
    Nagasawa M; Nakamura S; Miyazaki M; Nojima Y; Hayakawa H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):259-69. PubMed ID: 12199110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Attenuation of arbekacin-induced nephrotoxicity in rats by pazufloxacin mesilate].
    Kizawa K; Miyazaki M; Nagasawa M; Ogake N; Nagai A; Sanzen T; Kawamura Y
    Jpn J Antibiot; 2003 Feb; 56(1):44-54. PubMed ID: 12723398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamic target attainment of intravenous pazufloxacin in the bile of patients undergoing biliary pancreatic surgery.
    Uegami S; Ikawa K; Ohge H; Nakashima A; Shigemoto N; Morikawa N; Murakami Y; Sueda T
    J Chemother; 2014 Oct; 26(5):287-92. PubMed ID: 24552254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
    Fukuda H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
    Nomura N; Mitsuyama J; Furuta Y; Yamada H; Nakata M; Fukuda T; Yamada H; Takahata M; Minami S
    Jpn J Antibiot; 2002 Aug; 55(4):412-39. PubMed ID: 12378871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics and pharmacodynamic target attainment of pazufloxacin in prostate tissue: Dosing considerations for prostatitis.
    Nakamura K; Ikawa K; Nishikawa G; Kobayashi I; Narushima M; Muramatsu H; Morinaga S; Kajikawa K; Kato Y; Watanabe M; Zennami K; Kanao K; Morikawa N; Sumitomo M
    J Infect Chemother; 2017 Dec; 23(12):809-813. PubMed ID: 28923301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terbium-sensitized fluorescence method for the determination of pazufloxacin mesilate and its application.
    Chen S; Ma H; Zhao H; Feng R; Jin L
    Anal Sci; 2004 Jul; 20(7):1075-8. PubMed ID: 15293405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of target attainment rate of pazufloxacin mesilate using Monte Carlo simulation method].
    Abe N; Fukuda S; Nakamura A; Taguchi Y; Matsuo S
    Jpn J Antibiot; 2010 Aug; 63(4):319-25. PubMed ID: 21298865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction between shuanghuanglian and azithromycin injection: a nonlinear mixed-effects model analysis in rats.
    Tian J; Sun S; Zhao Z; Li X
    Xenobiotica; 2019 Nov; 49(11):1344-1351. PubMed ID: 30457423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological properties and expected clinical role of an injectable new quinolone antibiotic, pazufloxacin mesilate].
    Minami S; Hattori R; Matsuda A
    Nihon Yakurigaku Zasshi; 2003 Aug; 122(2):161-78. PubMed ID: 12890902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical pharmacokinetics/pharmacodynamics study on pazufloxacin methanesulphonate injection].
    Wang XG; Miao J; Liang DR; Yu Q; Liang MZ; Zhang SH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):689-93. PubMed ID: 19764574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of pazufloxacin mesilate, a new quinolone antibacterial agent, for intravenous use on QT interval].
    Fukuda H; Morita Y; Shiotani N; Mizuo M; Komae N
    Jpn J Antibiot; 2004 Aug; 57(4):404-12. PubMed ID: 15535041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma disposition of cefoperazone after single intravenous and intramuscular administrations in camels (Camelus dromedarius).
    Aboubakr M; Soliman A; Uney K; Elmas M
    Acta Vet Hung; 2018 Sep; 66(3):444-450. PubMed ID: 30264621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of enrofloxacin following intravenous administration to greater rheas: a preliminary study.
    de Lucas JJ; Rodríguez C; Martella MB; Lábaque MC; Navarro JL; San Andrés MI
    Res Vet Sci; 2005 Jun; 78(3):265-7. PubMed ID: 15766947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of single doses of cefoperazone given by the intravenous and intramuscular routes to unweaned calves.
    Soback S; Ziv G
    Res Vet Sci; 1989 Sep; 47(2):158-63. PubMed ID: 2799072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of pazufloxacin mesilate in Legionnaires' disease: a case report and in vitro study of the isolate.
    Higa F; Shinzato T; Toyama M; Haranaga S; Furugen M; Tateyama M; Kawakami K; Saito A
    J Infect Chemother; 2005 Jun; 11(3):164-8. PubMed ID: 15990982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of marbofloxacin in vulture (Gyps fulvus) after intravenous administration of a single dose.
    Garcia-Montijano M; Waxman S; de Lucas JJ; Luaces I; de San Andrés MD; Rodríguez C
    Res Vet Sci; 2011 Apr; 90(2):288-90. PubMed ID: 20605034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.